Cadralazine
Cadralazine is a vasodilator that is used in the treatment of hypertension. It is a member of the hydrazinophthalazine class of drugs, which also includes dihydralazine and hydralazine. Cadralazine works by relaxing the smooth muscle in the walls of arteries and veins, which reduces the resistance to blood flow and lowers blood pressure.
Mechanism of Action[edit | edit source]
Cadralazine's mechanism of action is not fully understood, but it is believed to work by inhibiting the release of calcium ions in the smooth muscle cells of the blood vessels. This causes the muscle cells to relax, which dilates the blood vessels and reduces blood pressure. Cadralazine may also have a direct effect on the endothelium, the layer of cells that lines the inside of blood vessels, which can further enhance its vasodilatory effects.
Pharmacokinetics[edit | edit source]
After oral administration, cadralazine is rapidly absorbed from the gastrointestinal tract. It is metabolized in the liver and excreted in the urine. The half-life of cadralazine is approximately 2 to 4 hours, which allows for once or twice daily dosing.
Side Effects[edit | edit source]
Like all medications, cadralazine can cause side effects. The most common side effects are headache, dizziness, and tachycardia. Less common side effects include nausea, vomiting, and diarrhea. Rare but serious side effects include hypotension, angina pectoris, and myocardial infarction.
Contraindications[edit | edit source]
Cadralazine is contraindicated in patients with known hypersensitivity to hydrazinophthalazine derivatives. It should also be used with caution in patients with renal impairment or hepatic impairment, as these conditions can affect the metabolism and excretion of the drug.
Interactions[edit | edit source]
Cadralazine can interact with other medications, including other antihypertensive drugs, diuretics, and beta blockers. These interactions can increase the risk of side effects or reduce the effectiveness of the medications.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
